Skip to main content

Table 3 The regimens of adjuvant chemotherapy

From: Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer

  

Venous invasion

 
 

N

Present

Absent

P-value

Regimen

     
 

S-1

41

23(24%)

18(19%)

0.346

S-1 plus cisplatin

14

10(10%)

4(4%)

0.086

5-FU plus methotrexate

12

4(4%)

8(8%)

0.200

UFT

12

5(5%)

7(7%)

0.511

S-1 plus paclitaxel

7

2(2%)

5(5%)

0.221

5-FU plus cisplatin

5

3(3%)

2(2%)

0.662

5-FU

5

1(1%)

4(4%)

0.148

Paclitaxel

1

1(1%)

0(0%)

0.241